Andres Briseno
Fortune : 986 388 $ au 30/06/2026
Fortune : 986 388 $ au 30/06/2026
Andres Ruiz Briseno is Chief Accounting Officer at IDEAYA Biosciences, Inc. since 2025.
Previously, Mr. Briseno was Associate Director-Financial Planning & Analysis at Pharmacyclics LLC from 2013 to 2016.
Mr. Briseno completed an undergraduate degree at San Jose State University in 2009.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC. 0,03 % | 07/07/2026 | 26 466 ( 0,03 % ) | 986 388 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/08/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national